C.R. Bard to buy Medafor for $200M

C.R. Bard (BCR) will acquire Medafor for $200M up-front and $80M in revenue-based milestone payments over the next two years.

The deal is expected to add 1% to FY14 revenue growth and will be "a few cents dilutive" to adjusted EPS this year. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs